Solve Therapeutics
Clinical trials sponsored by Solve Therapeutics, explained in plain language.
-
New drug SLV-154 enters human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called SLV-154 in about 70 people with advanced solid tumors (like head and neck, lung, breast, or ovarian cancer) that have spread. The main goal is to find a safe dose and check for side effects. Researchers will also watch for any signs …
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for advanced cancer? SLV-324 enters first human trial
Disease control Recruiting nowThis early-stage trial tests a new drug called SLV-324 in about 70 people with metastatic solid tumors that have worsened after standard treatments. The main goal is to find a safe dose and check for side effects. Researchers will also look at how the drug moves through the body …
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can a radioactive antibody light up hidden cancers on PET scans?
Diagnosis Recruiting nowThis early-phase trial is testing whether a new imaging agent called SLR-108 can improve PET scans for people with metastatic solid tumors. SLR-108 is an antibody that carries a small amount of radioactivity and is designed to attach to tumor cells, making them more visible on a …
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC